MedTrace Logo

Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT

NCT04789395 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2021-03-09

No results posted yet for this study

Summary

It is known that enhances wound healing by oxidative stress and supports immune system besides it is cheap and has not any side effects. Aim of the study is to prevent pulmonary fibrosis by using ozone therapy as a supportive therapy on the patients who have pneumonia and ground glass opacity on thorax CT both in ICU and wards. Patients will follow for a year.

Conditions

  • Ozone Therapy for Covid 19 Pneumonia Patients

Sponsors & Collaborators

  • Gaziosmanpasa Research and Education Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-02
Primary Completion
2021-09-20
Completion
2021-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04789395 on ClinicalTrials.gov